Research Keyword: mitochondrial dysfunction

Asymmetric mitonuclear interactions trigger transgressive inheritance and mitochondria-dependent heterosis in hybrids of the model system Pleurotus ostreatus

mycolabadmin

This research examines how mushroom hybrids inherit different combinations of genes from their parents, specifically looking at genes in the nucleus versus the mitochondria (cellular energy factories). When mushrooms with mismatched nuclear and mitochondrial genes are crossed, some grow slowly and show stress, while others surprisingly grow very well. The study identifies which genes are activated under these conditions and how they affect mushroom production quality and yield.

Read More »

Impact of a Formulation Containing Chaga Extract, Coenzyme Q10, and Alpha-Lipoic Acid on Mitochondrial Dysfunction and Oxidative Stress: NMR Metabolomic Insights into Cellular Energy

mycolabadmin

A new supplement formula combining Chaga mushroom extract, Coenzyme Q10, and alpha-lipoic acid was tested on nerve cells in the laboratory. The formula increased the cells’ energy production and protected them from harmful oxidative stress. This could potentially help people with conditions like fibromyalgia and neurodegenerative diseases that involve mitochondrial dysfunction.

Read More »

Cerebral Hypoxia-Induced Molecular Alterations and Their Impact on the Physiology of Neurons and Dendritic Spines: A Comprehensive Review

mycolabadmin

This review explains how low oxygen levels in the brain damage nerve cells and their connection points (dendritic spines) through a cascade of molecular changes. The brain normally has protective mechanisms, but severe or prolonged hypoxia overwhelms these defenses, leading to memory loss and cognitive problems. Several molecular pathways and supporting cells called astrocytes and microglia can help protect neurons. Understanding these protective mechanisms may lead to new treatments for brain conditions caused by low oxygen, such as stroke.

Read More »

Caged-hypocrellin mediated photodynamic therapy induces chromatin remodeling and disrupts mitochondrial energy metabolism in multidrug-resistant Candida auris

mycolabadmin

Researchers developed a new photodynamic therapy treatment using a light-activated compound called COP1T-HA to fight drug-resistant Candida auris infections. The therapy works by reorganizing the fungal cell’s genetic material architecture and disrupting energy production in mitochondria, ultimately killing the fungal cells. This approach represents a novel strategy to overcome antibiotic resistance, as it targets multiple cellular processes rather than a single pathway that fungi can easily resist.

Read More »
Scroll to Top